Despite a century of development and refinement of insulin therapy, hypoglycaemia remains the most common complication, affecting virtually all people with type 1 diabetes and most of those with insulin-treated type 2 diabetes [ 1 ]. Thus, people …

Achieving optimal glycemic outcomes is critical for effective management of diabetes, and basal-bolus treatment regimens are currently seen as the standard of care for insulin injection therapy for fasting and post-prandial glucose in people with …

The rising prevalence of gestational diabetes mellitus (GDM) globally has become an alarming issue recently [ 1 , 2 ]. GDM has a significant impact not only on the outcomes of pregnancy [ 3 , 4 ] but also on the risk of developing type 2 diabetes …

The global prevalence of type 2 diabetes mellitus, a common metabolic disorder, has been increasing rapidly in recent years [ 1 ] . As a result, the comprehensive care and prevention of diabetic complications, including microvascular and …

The non-communicable diseases (NCD) are the leading cause of premature morbidity and mortality. Globally, there are around 537 million adults aged 20–79 years currently living with diabetes and India alone accommodates around 77 million diabetic …

Diabetes mellitus (DM) is regarded as one of the most critical public health challenges of the 21st century. It has evolved into a burgeoning epidemic since the last century, and today ranks among the major causes of mortality worldwide. Diabetes …

For women with pre-existing diabetes who become pregnant, diabetes management will be at the center of their pregnancy journey. Pre-existing diabetes is type 1 diabetes (T1D) or type 2 diabetes (T2D) that is present before pregnancy and pregnancy …

Diabetes is a heritable disease. Evidences from twin or family based studies have demonstrated the estimated heritability ranging from 30 to 70% depending on the age at onset [ 1 – 3 ]. Additionally, the strongest heritability for type 2 diabetes …

Type 2 diabetes (T2D) is a significant health concern in the USA with > 30 million adults diagnosed with the disease [ 1 ]. The already high prevalence of T2D is expected to increase by almost 50% globally by 2045 [ 2 ]. About one in four people …

Diabetes is a global health priority, presenting a significant challenge to the health and well-being of individuals living with the condition, their families and societies [ 1 , 2 ]. In Australia, more than 1.5 million people have diabetes, with …

Hypoglycemia constitutes the commonest acute complication of type 1 diabetes mellitus (T1DM) [ 1 ]. Aggressive HbA1c goals may increase the frequency of hypoglycemia, which represents a major limiting factor in the glycemic control of T1DM [ 2 ].

During the recent coronavirus disease 2019 (COVID-19) pandemic, nationwide lockdowns were imposed in most countries to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [ 1 – 4 ]. Patients with diabetes mellitus …

Gestational Diabetes Mellitus (GDM) has been on the rise for the last two decades along with the growing incidence of obesity. The ubiquitous use of Endocrine-Disrupting Chemicals (EDCs) worldwide has been associated with this increase in GDM …

The risks of ischemic and hemorrhagic stroke and poor neurological outcomes after stroke are increased in people with type 2 diabetes. Explore how to manage the hyperacute stroke stage and prevent CV disease.